MXPA05009902A - Formulaciones topicas foto-estabilizadas de ketoprofeno que contienen dos filtros uv. - Google Patents
Formulaciones topicas foto-estabilizadas de ketoprofeno que contienen dos filtros uv.Info
- Publication number
- MXPA05009902A MXPA05009902A MXPA05009902A MXPA05009902A MXPA05009902A MX PA05009902 A MXPA05009902 A MX PA05009902A MX PA05009902 A MXPA05009902 A MX PA05009902A MX PA05009902 A MXPA05009902 A MX PA05009902A MX PA05009902 A MXPA05009902 A MX PA05009902A
- Authority
- MX
- Mexico
- Prior art keywords
- filters
- photostabilized
- topical formulations
- skin
- ketoprofen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Esta invencion esta relacionada con formulaciones farmaceuticas topicas que contienen ketoprofeno o su isomero S(+) dexketoprofeno o mezlcas de los dos isomeros, juntos con dos filtros UV, de preferencia cinamato de octil metoxi y acido fenil bencimidazol sulfonico, y un anti-oxidante, de preferencia butil hidroxi tolueno (BHT). Las formulaciones facilitan una foto-estabilidad del principio activo, tiene ningun o muy poco efecto irritante en la piel, se toleran bien, y presentan una adecuada penetracion a traves de la piel.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000070A ITFI20030070A1 (it) | 2003-03-18 | 2003-03-18 | Formulazioni topiche stabilizzate contenenti ketoprofene |
PCT/EP2004/050317 WO2004082580A2 (en) | 2003-03-18 | 2004-03-17 | Photostabilized topical formulations of ketoprofen containing two uv filters |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05009902A true MXPA05009902A (es) | 2006-03-21 |
Family
ID=33017958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05009902A MXPA05009902A (es) | 2003-03-18 | 2004-03-17 | Formulaciones topicas foto-estabilizadas de ketoprofeno que contienen dos filtros uv. |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1613300B1 (es) |
KR (1) | KR20060008869A (es) |
CN (1) | CN1767824A (es) |
AT (1) | ATE416763T1 (es) |
CY (1) | CY1108869T1 (es) |
DE (1) | DE602004018291D1 (es) |
DK (1) | DK1613300T3 (es) |
ES (1) | ES2321837T3 (es) |
IT (1) | ITFI20030070A1 (es) |
MA (1) | MA27669A1 (es) |
MX (1) | MXPA05009902A (es) |
MY (1) | MY140025A (es) |
PL (1) | PL1613300T3 (es) |
PT (1) | PT1613300E (es) |
RU (1) | RU2340335C2 (es) |
SI (1) | SI1613300T1 (es) |
TW (1) | TWI327912B (es) |
UA (1) | UA82871C2 (es) |
WO (1) | WO2004082580A2 (es) |
ZA (1) | ZA200508153B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2089007A2 (en) | 2006-10-27 | 2009-08-19 | Noven Pharmaceuticals, INC. | Transdermal delivery of ketoprofen polar derivatives |
EP2153814A1 (en) | 2008-08-05 | 2010-02-17 | Isdin S.A. | Use of compositions comprising urea |
EP2153815A1 (en) | 2008-08-05 | 2010-02-17 | Isdin S.A. | Use of urea containing compositions |
JP5123333B2 (ja) | 2010-01-26 | 2013-01-23 | 株式会社 資生堂 | 油中水型乳化日焼け止め化粧料 |
CN102068405A (zh) * | 2010-12-16 | 2011-05-25 | 天津工业大学 | 一种酮洛芬凝胶及其制备方法 |
WO2013022410A2 (en) | 2011-08-08 | 2013-02-14 | Mahmut Bilgic | Production method for effervescent formulations comprising dexketoprofen |
US8822537B2 (en) * | 2012-09-27 | 2014-09-02 | Achelios Therapeutics, Inc. | Topical ketoprofen composition |
CN103804184B (zh) * | 2014-02-14 | 2016-02-03 | 南京科胜医药科技有限公司 | 精氨酸酮洛芬的晶型及制备方法 |
RU2667465C2 (ru) * | 2015-10-28 | 2018-09-19 | Закрытое Акционерное Общество "Фармфирма "Сотекс" | Фармацевтическая композиция для наружного применения, содержащая соль декскетопрофена, и способ ее получения |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60155111A (ja) * | 1983-10-20 | 1985-08-15 | Hisamitsu Pharmaceut Co Inc | 安定なケトプロフェン含有外用経皮製剤 |
AU8903591A (en) * | 1990-10-05 | 1992-04-28 | Miles Inc. | Prevention or treatment of sunburn using the s(+) isomer of ketoprofen |
AU8927191A (en) * | 1990-10-05 | 1992-04-28 | Analgesic Associates | Prevention or treatment of sunburn using the s(+) isomer of flurbiprofen |
US5185373A (en) * | 1991-08-13 | 1993-02-09 | American Home Products Corporation | Inhibition of thermal degradation of ibuprofen |
DE4444238A1 (de) * | 1994-12-13 | 1996-06-20 | Beiersdorf Ag | Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden |
AUPN814496A0 (en) * | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
FR2804024B1 (fr) * | 2000-01-21 | 2002-09-13 | Menarini France | Nouvelles compositions pharmaceutiques a action anti- inflammatoire et leur procede de preparation |
WO2001068061A1 (fr) * | 2000-03-17 | 2001-09-20 | Hisamitsu Pharmaceutical Co., Inc. | Preparation adhesive protegeant des uv |
-
2003
- 2003-03-18 IT IT000070A patent/ITFI20030070A1/it unknown
-
2004
- 2004-03-10 TW TW093106275A patent/TWI327912B/zh active
- 2004-03-15 MY MYPI20040902A patent/MY140025A/en unknown
- 2004-03-17 PT PT04721199T patent/PT1613300E/pt unknown
- 2004-03-17 KR KR1020057017267A patent/KR20060008869A/ko not_active Application Discontinuation
- 2004-03-17 EP EP04721199A patent/EP1613300B1/en not_active Expired - Lifetime
- 2004-03-17 MX MXPA05009902A patent/MXPA05009902A/es active IP Right Grant
- 2004-03-17 SI SI200431048T patent/SI1613300T1/sl unknown
- 2004-03-17 RU RU2005132004/15A patent/RU2340335C2/ru not_active IP Right Cessation
- 2004-03-17 AT AT04721199T patent/ATE416763T1/de not_active IP Right Cessation
- 2004-03-17 DK DK04721199T patent/DK1613300T3/da active
- 2004-03-17 UA UAA200509210A patent/UA82871C2/uk unknown
- 2004-03-17 DE DE602004018291T patent/DE602004018291D1/de not_active Expired - Lifetime
- 2004-03-17 CN CNA2004800067627A patent/CN1767824A/zh active Pending
- 2004-03-17 PL PL04721199T patent/PL1613300T3/pl unknown
- 2004-03-17 ES ES04721199T patent/ES2321837T3/es not_active Expired - Lifetime
- 2004-03-17 WO PCT/EP2004/050317 patent/WO2004082580A2/en active Search and Examination
-
2005
- 2005-09-30 MA MA28524A patent/MA27669A1/fr unknown
- 2005-10-10 ZA ZA200508153A patent/ZA200508153B/en unknown
-
2009
- 2009-03-06 CY CY20091100257T patent/CY1108869T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
RU2340335C2 (ru) | 2008-12-10 |
KR20060008869A (ko) | 2006-01-27 |
RU2005132004A (ru) | 2006-02-27 |
EP1613300B1 (en) | 2008-12-10 |
SI1613300T1 (sl) | 2009-06-30 |
WO2004082580A3 (en) | 2005-01-27 |
PL1613300T3 (pl) | 2009-05-29 |
TWI327912B (en) | 2010-08-01 |
UA82871C2 (en) | 2008-05-26 |
PT1613300E (pt) | 2009-03-27 |
TW200509897A (en) | 2005-03-16 |
DE602004018291D1 (de) | 2009-01-22 |
CY1108869T1 (el) | 2014-07-02 |
WO2004082580A2 (en) | 2004-09-30 |
ITFI20030070A1 (it) | 2004-09-19 |
EP1613300A2 (en) | 2006-01-11 |
ES2321837T3 (es) | 2009-06-12 |
DK1613300T3 (da) | 2009-03-09 |
ZA200508153B (en) | 2007-10-31 |
MA27669A1 (fr) | 2005-12-01 |
ATE416763T1 (de) | 2008-12-15 |
CN1767824A (zh) | 2006-05-03 |
MY140025A (en) | 2009-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108869T1 (el) | Φωτοσταθεροποιημενα τοπικα σκευασματα κετοπροφαινης που περιεχουν δυο φιλτρα uv | |
WO2007096601A3 (en) | Antimicrobial formulations comprising a quinone and a copper salt | |
WO2004017920A3 (en) | Novel biphenyl and biphenyl-like cannabinoids | |
MY142589A (en) | Benzimidazole derivatives : preparation and pharmaceutical applications | |
NO20060416L (no) | Ny anvendelse I | |
WO2005016286A3 (en) | Pyrazine modulators of cannabinoid receptors | |
WO2004105722A8 (en) | A formulation for chemical peeling | |
HK1079446A1 (en) | Pharmeceutical solid dispersions of modafinil compounds | |
WO2004055006A8 (en) | Novel compounds having selective inhibiting effect at gsk3 | |
WO2007014124A3 (en) | High drug load formulations and dosage forms | |
ES2124983T5 (es) | Utilizacion de un antagonista de substancia p para el tratamiento de las manchas rojas cutaneas de origen neurogeno. | |
CA2441461A1 (en) | Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia | |
WO2005016249A3 (en) | Compositions of a chromene or phenyl acetic acid cyclooxygenase-2 selective inhibitor and an ace inhibitor for the treatment of central nervous system damage | |
WO2003092655A3 (de) | Verwendung von wirkstoffmischungen mit azelainsaure und glycyrrhetinsaure als anti-aknemittel | |
TW200507838A (en) | Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator | |
MY139295A (en) | Stabilised topical formulations containing ketoprofen | |
WO2004093816A3 (en) | Compositions comprising a selective cox-2 inhibitor and a calcium modulating agent | |
DK1666473T3 (da) | Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens | |
WO2004098522A3 (en) | Gemini vitamin d3 compounds and methods of use thereof | |
WO2003061572A3 (en) | Anti-inflammatory formulations | |
MXPA05008243A (es) | Formulacion mejorada para agentes aclarantes de la piel. | |
EP1273301A3 (en) | Pharmaceutical preparations based on active ingredients susceptible to illict administration | |
WO2001003669A3 (en) | Delivery of liposomal-encapsulated antioxidants and applications thereof | |
WO2004105699A3 (en) | Compositions of a cyclooxygenase-2 selective inhibitor and a cannabinoid agent for the treatment of central nervous system damage | |
WO2009125117A3 (fr) | Composition dermatologique utilisable notamment pour le soin et la prevention des escarres |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |